Literature DB >> 2872161

Increased plasma vasopressin in low renin essential hypertension.

I Os, S E Kjeldsen, J Skjøtø, A Westheim, K Lande, I Aakesson, P Frederichsen, P Leren, I Hjermann, I K Eide.   

Abstract

Baseline plasma vasopressin concentrations were measured in 48 men (all 50 years old) with decreased plasma renin concentration and untreated, sustained essential hypertension and in 29 healthy normotensive men. Mean hypertensive plasma vasopressin concentration was more than twice as high as the corresponding normotensive level (15.7 +/- 2.2 [SE] vs 7.5 +/- 1.0 pg/ml; p less than 0.001). Plasma renin concentration in the hypertensive group was reduced compared with that in the normotensive group (0.28 +/- 0.04 vs 0.46 +/- 0.06 Goldblatt units X 10(-4)/ml). These differences appeared despite virtually identical serum osmolality, creatinine clearance, and urinary sodium excretion in the two groups. In the first 38 hypertensive subjects, arterial plasma epinephrine concentrations were significantly increased over those of the first 28 control subjects (99 +/- 12 vs 68 +/- 6 pg/ml; p less than 0.025). In contrast to those with low renin essential hypertension, 35 men with normal renin essential hypertension (all 40 years old) had normal plasma vasopressin levels that were not significantly different from those in a comparable normotensive control group (3.7 +/- 0.8 vs 3.5 +/- 0.4 pg/ml). Arterial epinephrine concentrations were not significantly different between normal renin subjects and the control group. After 6 weeks of treatment with the nonselective beta-adrenergic receptor blocker oxprenolol in 11 subjects with low renin hypertension, blood pressure was reduced and the plasma vasopressin concentration fell from 27.6 +/- 6.4 to 13.5 +/- 4.2 pg/ml (p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872161     DOI: 10.1161/01.hyp.8.6.506

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

1.  Increased activity of the orexin system in the paraventricular nucleus contributes to salt-sensitive hypertension.

Authors:  Michael J Huber; Yuanyuan Fan; Enshe Jiang; Fengli Zhu; Robert A Larson; Jianqun Yan; Ningjun Li; Qing-Hui Chen; Zhiying Shan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-30       Impact factor: 4.733

Review 2.  Role of Vasopressin in Rat Models of Salt-Dependent Hypertension.

Authors:  Masha Prager-Khoutorsky; Katrina Y Choe; David I Levi; Charles W Bourque
Journal:  Curr Hypertens Rep       Date:  2017-05       Impact factor: 5.369

3.  Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent.

Authors:  Nicole K Littlejohn; Rick B Siel; Pimonrat Ketsawatsomkron; Christopher J Pelham; Nicole A Pearson; Aline M Hilzendeger; Beth A Buehrer; Benjamin J Weidemann; Huiping Li; Deborah R Davis; Anthony P Thompson; Xuebo Liu; Martin D Cassell; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-27       Impact factor: 3.619

4.  Regulation of vasopressin release in moderately severe essential hypertension.

Authors:  A Del Bo; M Marabini; A Morganti; A Zanchetti
Journal:  Clin Auton Res       Date:  1991-06       Impact factor: 4.435

5.  Arterial plasma vasopressin and aldosterone predict left ventricular mass in men who develop hypertension over 20 years.

Authors:  Arne H Strand; Helga Gudmundsdottir; Eigil Fossum; Ingrid Os; Reidar Bjørnerheim; Sverre E Kjeldsen
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-05       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.